Hyderabad, 29 July (IANS) A new study has shown that eating millets reduces the risk of developing type 2 diabetes and helps manage blood glucose levels in people with diabetes.The study indicates the potential to design appropriate meals with millets for diabetic and pre-diabetic people as well as for non-diabetic people as a preventive approach.Drawing on research from 11 countries, the study published in Frontiers in Nutrition shows that diabetic people who consumed millets as part of their daily diet saw their blood glucose levels drop 12-15% (fasting and post-meal), and blood glucose levels went from diabetic to pre-diabetes levels.The HbA1c (blood glucose bound to hemoglobin) levels lowered on average 17% for pre-diabetic individuals, and the levels went from prediabetic to normal status. These findings affirm that eating millets can lead to a better glycemic response.The authors reviewed 80 published studies of which 65 were eligible for a meta-analysis involving about 1,000 human subjects, making this analysis the largest systematic review on the topic till date, said International Crops Research Institute for the Semi-Arid Tropics (ICRISAT)."No one knew there were so many scientific studies undertaken on millets' effect on diabetes. These benefits were often contested, and this systematic review of the studies published in scientific journals has proven that millets keep blood glucose levels in check, reducing the risk of diabetes, and has shown just how well these smart foods do it," said Dr. S Anitha, the study's lead author and a senior nutrition scientist at International Crops Research Institute for the Semi-Arid Tropics (ICRISAT)."Diabetes contributed to very high disease burden from 1990-2016 in India. Diabetes-related health expenditure was over $7 million. There is no easy solution, and it requires a lifestyle change, and diet is a very important part of this. This study provides one part of the solution useful for individuals and governments. How we use this and implement it into programs needs careful planning," said Hemalatha, Director, National Institute of Nutrition (NIN).Raj Bhandari, one of the study's authors and a representative on the Indian National Technical Board of Nutrition, noted that additional attention to our health has been accelerated due to Covid-19 and diabetics are even more vulnerable to the virus. "Our diets play a critical role and if we could bring millets back as a major part of our diet, we would not only help in controlling diabetes, but we would also be adding important nutrients to our plate."According to the International Diabetes Association, diabetes is increasing in all regions of the world. India, China and the US have the highest numbers of people with diabetes. Africa has the largest forecasted increase of 143% from 2019 to 2045, the Middle East and North Africa 96% and South East Asia 74%. The authors urge the diversification of staples with millets to keep diabetes in check, especially across Asia and Africa.Strengthening the case for returning millets as staples, the study found that millets have a low average glycemic index (GI) of 52.7, about 30% lower glycemic index (GI) than milled rice and refined wheat, and about 14-37 GI points lower compared to maize. All 11 types of millets studied were either low (
London, July 28 (IANS) Researchers have found that strokes were a common complication experienced by hospitalised adults with severe Covid-19, with higher rates than expected amongst younger people.The study, led by a team at the University of Southampton in the UK, showed that risk factors such as diabetes and high blood pressure, contributed to the risk of stroke, including in younger people.The study, published in the journal Brain Communications, looked into 267 cases of Covid-19 related neurological and psychiatric problems in the UK.Of the 267 cases, strokes were the most frequently reported conditions, affecting nearly half of the patients. Over a quarter of strokes occurred in patients under 60 years old, many of whom had modifiable risk factors that meant they were already at risk of stroke.Other common conditions included delirium, psychiatric events and other evidence of damage to the brain (encephalopathy). More than 10 per cent of patients experienced more than one neurological condition, and these patients were more likely to require intensive care and ventilation."It was striking not only how many different neurological and psychiatric events we observed in this study, but also that some of these conditions occurred together within the same patients. This suggests Covid can affect multiple parts of the nervous system in the same patient," said Dr Amy Ross-Russell, research fellow at the NIHR Southampton Clinical Research Facility at University Hospital Southampton NHS Foundation Trust."Patients with strokes also had blood vessel blockages or thrombosis elsewhere in the body so this is important for understanding why some strokes occur during Covid-19," Ross-Russell added.The finding suggests that Covid-19 amplifies the risk of stroke, including in younger people. Public health measures could reduce this, including lifestyle measures to avoid developing diabetes and high blood pressure, good control of blood sugar and blood pressure, and avoiding the risk of severe Covid-19 through vaccination and other public health measures.--IANSrvt/dpb
<br>This move by the RSS is being seen as an attempt to popularise the ancient knowledge of Ayurveda. This campaign being spearheaded by the Sangh is seen as a strategy to establish itself on the ground by going door-to-door before the 2022 Uttar Pradesh Assembly elections.Amid the impending possibility of the third wave of Covid-19, the Sangh's subsidiary organisation Arogya Bharati has been spearheading this campaign 'Do Boond Immunity' to increase immunity in children. Under this campaign, a special medicine will be given to children aged between 1 to 16 years in a particular constellation.S.N. Shankhwar, King's George Medical University (KGMU) Chief Medical Officer and Metropolitan President of Arogya Bharati, said that all preparations for the campaign have been completed and it will be launched on August 7.Shankhwar said 'Suvarna Prashan' has been given a lot of importance in Ayurveda and prescribing it in a particular constellation 'Pushya Nakshatra' increases the immunity of children at a fast rate. He said that in eastern UP districts which were affected by Japanese Encephalitis, children were given 'Suvarna Prashan' medicine which yielded good results.Another RSS official said, "This medicine has been specially ordered from Gujarat. 'Suvarna Prashan' has been coined by combining two words 'Swarna' which means gold and 'Prashan' meaning licking. Apart from Swarna Bhasma in 'Suvarna Prashan', many other Ayurvedic medicines like Kesar, Shankhpushpi, Shariba, Balghrit, Guduchi, Sarasava, honey and cow's ghee are used. Although this Suvarna Prashan is given to children from birth till 16 years in every Pushya Nakshatra but it can also be prescribed for children above 16 years."Shankhwar said, "This campaign will start from August 7 and will run till June 4, 2022. Under this campaign, the time and days have been fixed according to the period of the constellation.""A total of 27 constellations have been listed in astrology, out of which some constellations are considered auspicious and several others inauspicious. Pushya is the 8th nakshatra among the 27 nakshatras. Pushya Nakshatra is considered very auspicious. Lord Ram was born in this constellation. When this Nakshatra falls on Thursday and Sunday of the week, then a 'Mahayog' is formed on this day. When Pushya Nakshatra falls on Thursday, it is called Guru-Pushya Yog and when it falls on Sunday, it is called Ravi-Pushya Yog. The Lord of these constellations is Brihaspati Dev."--IANS<br>vkt-rjs/khz/bg
Bengaluru, July 26 (IANS) Leading biotech major Biocon's arm Biocon Biologics Ltd on Monday said it would make an antibody in partnership with the US-based Adagio Therapeutics to treat Covid symptoms."Adagio has granted an exclusive license to us to manufacture and market an antibody for treating Covid in India and select emerging markets," said the city-based integrated biosimilars firm in a statement.The drug (ADG20) is a novel monoclonal antibody, which targets the spike protein of Sars-CoV-2 and related coronaviruses. It is in a global clinical development by Adagio as an agent to treat and prevent Covid. "The drug can enable outpatient administration as a single injection to prevent and treat Covid symptoms," said the statement.The drug has been designed and engineered to have high potency for neutralising the infection."The drug has the potential to impact viral replication and subsequent disease through multiple mechanisms of action," said the company.Adagio is advancing the drug through multiple clinical trials on a global basis."The antibody has a long half-life, which allows for immediate and durable protection against Covid up to 1 year," added the statement.--IANSfb/vd
New York, July 24 (IANS) While diabetes is known to be a risk factor for severe Covid outcomes, researchers are now observing a new long-term health concern in patients hospitalised with Covid-19 -- an increase in new-onset hyperglycemia, or high levels of blood sugar lasting months after the infection.Researchers from the Boston Children's Hospital assessed the health of 551 people admitted to the hospital for Covid-19 in Italy from March through May 2020.About half of the patients (46 per cent), with no history of diabetes, were found to have new hyperglycemia. A follow-up showed that while most cases were resolved, about 35 per cent of the newly hyperglycemic patients remained so at least six months after the infection, said lead author of the study, Paolo Fiorina, from the Division of Nephrology at the hospital.Compared to patients with no signs of glucose abnormalities, the hyperglycemic patients also had worse clinical concerns: longer hospitalisation, worse clinical symptoms, a higher need of oxygen, a higher need of ventilation, and increased need of intensive care treatment.The study was published in the journal Nature Metabolism. The team also found that hyperglycemic patients had abnormal hormonal levels. "We discovered they were severely hyperinsulinemic; they produced too much insulin," Fiorina said.They also had abnormal levels of pro-insulin, a precursor of insulin, and markers of impaired islet beta cell function. Islet beta cells make and secrete insulin."Basically, the hormonal profile suggests that the endocrine pancreatic function is abnormal in those patients with Covid-19 and it persists long after recovery," Fiorina added.Hyperglycemic patients also had severe abnormalities in the amount of inflammatory cytokines, including IL-6 and others.While glucometabolic abnormalities declined over time in some patients -- particularly after Covid-19 infection -- other issues like higher post-prandial (after eating) glucose levels and abnormal pancreatic hormones remained in the post-Covid period."This study is one of the first to show that Covid-19 has a direct effect on the pancreas," Fiorina said, adding, "It indicates that the pancreas is another target of the virus affecting not only the acute phase during hospitalisation but potentially also the long-term health of these patients."The study pointed to the importance of evaluating pancreatic function in patients hospitalised for Covid-19 -- while in the hospital and over the long term.--IANSrvt/arm
New Delhi, July 23 (IANS) The Associated Chambers of Commerce and Industry of India (ASSOCHAM), the apex trade association of the country, as part of its 'Illness to Wellness' campaign, today unveiled India's largest primary healthcare survey report on the rising burden of non-communicable diseases (NCD) in the county followed by a virtual panel discussion.
The report titled "Non-Communicable Diseases in India" covered 2,33,672 people and 673 public health offices in 21 states, to analyse the rising cases of NCDs in the country and the social profile of suffering households
Calling diabetes an overpowering non-communicable disease, Dr. Ambrish Mittal, Chairman and Head, Endocrinology and Diabetes Department, Max Healthcare (Pan Max), said, "Diabetes has risen exponentially in India from 2 per cent in the 1970s in urban areas to between 10-20 per cent in 2020. The cases of diabetes are even higher in metros at 35-40 per cent. This spike is linked to urbanization led by economic development and has been more prevalent in urban areas as compared to rural areas."
The Covid-19 pandemic has brought a sharper focus on health care. Patterns emerging from Covid management across the country indicate that people with co-morbidities of non-communicable diseases (NCDs) have a higher mortality rate than those who do not.
Report prepared by Thought Arbitrage Research Institute (TARI), the survey report observed that India's non-communicable disease burden is growing at an alarming rate with the average age for onset falling sharply.
It reported that NCDs increase after 18 years and show a quantum leap when an individual crosses the age of 35 years. It found that more than 2/3 of the individuals suffering from NCDs are in the most productive-life age groups i.e., between 26-59 years. This is an alarming trend and points to the grim reality that the burden of NCDs on India is long-lasting given that 65 per cent of the country's population is below 35 years of age.
The survey suggested that the prevalence of having any NCDs among the population is 116 per 1,000 population in India. It identified hypertension, digestive disease, and diabetes as the top three NCDs followed by respiratory diseases, brain/neurological disorders, heart diseases/CVD, kidney disorders, and cancer in the order of prevalence.
Rajinder K. Dhamija, Head of Neurology Department, Lady Hardinge Medical College New Delhi said, "The cases of stroke have grown 4 times in the last 30 years. This can be attributed to changes in the lifestyle and the demography of our country. It is worth noting that the life expectancy of our population has increased from 47 years in the 1970s to 70 years today. This means that we have a large aging population that is vulnerable to neurological diseases, dementia, stroke, etc. There is also an interesting trend of lower-income countries witnessing a rise in cases of vascular diseases like stroke and mortality, unlike developed countries that are more resourceful and yet registering a decline in such cases. This is due to an epidemic of diseases like diabetes and hypertension coupled with changes in lifestyle, an aging population, lack of physical activity, and air pollution."
On a collective basis, the report identified air pollution as the most prevalent risk factor among the surveyed population. It was trailed by low physical activity -- a key metabolic and physical activity and an imbalanced diet, a behavioural risk factor that occupied 3rd spot.
An imbalanced diet includes a diet low in legumes, milk, omega-3 fatty acids, vegetables, fruits, calcium etc. High consumption of sugar and trans-fats due to growing urbanisation often leads to sedentary and stressed lifestyle also contribute to factors that lead to an imbalanced diet.
Interestingly, chewing tobacco and tobacco consumption were found not to play any significant role in the occurrence of NCD, and alcohol consumption was found to have an even smaller impact on the prevalence of NCD. Together these intoxications, deeply connected to modern-day lifestyle, were found to have a much lesser impact on the occurrence of NCDs.
Throwing light on the co-morbidity of NCDs with each other, the study underlined that hypertension has the highest comorbidity with almost all NCDs. This is followed by diabetes, kidney, and digestive disorders in their relative simultaneous occurrence in morbidity. This coexistence, according to the survey, is followed by diabetes and respiratory diseases. On the other hand, cancer and kidney disease were found to have lower comorbidity.
The state of Odisha was found to have the highest prevalence of NCDs (272 per 1,000 population) while Gujarat registered the lowest prevalence (60 per 1,000). Andhra Pradesh, Telangana, and West Bengal were other states where NCD prevalence was higher than the national average. This calls for state-specific strategies to tackle NCDs.